| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense.
|
Nat Med
|
2008
|
4.93
|
|
2
|
Restoration of NET formation by gene therapy in CGD controls aspergillosis.
|
Blood
|
2009
|
4.06
|
|
3
|
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.
|
J Exp Med
|
2008
|
3.85
|
|
4
|
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
|
J Exp Med
|
2011
|
3.63
|
|
5
|
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.
|
Blood
|
2010
|
3.23
|
|
6
|
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
|
J Allergy Clin Immunol
|
2008
|
2.50
|
|
7
|
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries.
|
Medicine (Baltimore)
|
2010
|
2.33
|
|
8
|
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.
|
Medicine (Baltimore)
|
2010
|
2.26
|
|
9
|
Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
|
J Allergy Clin Immunol
|
2011
|
2.25
|
|
10
|
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
|
J Clin Invest
|
2003
|
1.92
|
|
11
|
Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes.
|
Eur J Immunol
|
2004
|
1.83
|
|
12
|
From idiopathic infectious diseases to novel primary immunodeficiencies.
|
J Allergy Clin Immunol
|
2005
|
1.54
|
|
13
|
Gene therapy of chronic granulomatous disease: the engraftment dilemma.
|
Mol Ther
|
2010
|
1.34
|
|
14
|
The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation.
|
Am J Hum Genet
|
2006
|
1.24
|
|
15
|
Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.
|
J Allergy Clin Immunol
|
2004
|
1.17
|
|
16
|
Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards.
|
J Pediatr
|
2009
|
1.15
|
|
17
|
Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects.
|
J Allergy Clin Immunol
|
2011
|
1.13
|
|
18
|
Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.
|
Stem Cells
|
2012
|
1.11
|
|
19
|
Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing.
|
J Cell Biol
|
2013
|
1.07
|
|
20
|
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
|
J Allergy Clin Immunol
|
2010
|
1.03
|
|
21
|
Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease.
|
Clin Immunol
|
2010
|
0.96
|
|
22
|
NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.
|
J Allergy Clin Immunol
|
2011
|
0.96
|
|
23
|
Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age.
|
Cerebellum
|
2010
|
0.87
|
|
24
|
Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome.
|
J Allergy Clin Immunol
|
2012
|
0.82
|
|
25
|
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
|
Hum Gene Ther Methods
|
2013
|
0.82
|
|
26
|
Gene therapy for chronic granulomatous disease: current status and future perspectives.
|
Curr Gene Ther
|
2014
|
0.81
|
|
27
|
Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia.
|
Pediatr Infect Dis J
|
2004
|
0.81
|
|
28
|
Modern management of primary B-cell immunodeficiencies.
|
Pediatr Allergy Immunol
|
2011
|
0.79
|
|
29
|
Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation.
|
J Allergy Clin Immunol
|
2011
|
0.79
|
|
30
|
Reactive oxygen species abrogate the anticarcinogenic effect of eicosapentaenoic acid in Atm-deficient mice.
|
Nutr Cancer
|
2010
|
0.77
|
|
31
|
Immunoglobulins and inflammatory cytokines in nasal secretions in humoral immunodeficiencies.
|
Laryngoscope
|
2006
|
0.75
|
|
32
|
Preliminary Evidence for a Compromised T-Cell Compartment in Maltreated Children with Depression and Posttraumatic Stress Disorder.
|
Neuroimmunomodulation
|
2015
|
0.75
|
|
33
|
A 19-month-old Boy With Refractory Cervical Adenitis.
|
Pediatr Infect Dis J
|
2019
|
0.75
|
|
34
|
Autosomal-dominant primary immunodeficiencies.
|
Curr Opin Hematol
|
2005
|
0.75
|
|
35
|
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome.
|
Eur J Pediatr
|
2006
|
0.75
|